| Announce Date | 11/04/2025 |
| EPS Normalized Actual | $3.11 (Beat by $2.42) |
| EPS GAAP Actual | $3.11 (Beat by $2.42) |
| Revenue Actual | $13.467B |
| Revenue Surprise | Beat by $13467M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.67 |
| EPS GAAP Estimate | $0.67 |
| Revenue Estimate | $13.308129122B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 6.19 | 13.71 | 5.78448 | 6.50434 | 10 |
| Dec 2028 | 4.484 | 18.92 | 4.17171 | 4.66748 | 14 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 3.18 | 2.67604 | 13.467B | 16.92% | 960.21M |
| FQ2 2025 (Jun 2025) | 0.65 | 0.65 | 12.651B | 15.42% | 12651M |
| FQ1 2025 (Mar 2025) | 0.85 | 0.85 | 11.533B | 12.16% | 11533M |
| FQ1 2017 (Mar 2017) | -0.55 | -0.55 | 1.529B | 100% | 1529M |
| FQ2 2017 (Jun 2017) | -0.62 | -0.62 | 1.813B | 100% | 1813M |
| FQ3 2017 (Sep 2017) | -0.84 | -0.84 | 2.149B | 100% | 2149M |
| FQ4 2017 (Dec 2017) | -0.38 | -0.38 | 2.441B | 100% | 2441M |
| FQ4 2024 (Dec 2024) | 3.27 | 3.27 | 11.959B | 16.92% | 11959M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.67
Consensus Revenue Estimates
13.308129122B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.16 | -- | 1.10763 | 1.19527 | 13 |
| FQ3 2027 (Sep 2027) | 1.05 | -- | 1.01606 | 1.08001 | 9 |
| FQ2 2027 (Jun 2027) | 0.98 | -- | 0.94833 | 1.00801 | 9 |
| FQ1 2027 (Mar 2027) | 0.95 | -- | 0.9144 | 0.97908 | 11 |
| FQ4 2026 (Oct 2026) | 0.74 | -- | 0.69704 | 0.78518 | 9 |
| FQ3 2026 (Jul 2026) | 0.7 | -354.29 | 0.65937 | 0.74274 | 9 |
| FQ2 2026 (Jun 2026) | 0.7 | 7.14 | 0.61167 | 0.75787 | 9 |
| FQ1 2026 (Mar 2026) | 0.67 | -26.87 | 0.58546 | 0.72539 | 9 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 18.64B | -- | 17.99B | 19.08B | 18 |
| FQ3 2027 (Sep 2027) | 26.61B | -- | 25.95B | 27.19B | 11 |
| FQ2 2027 (Jun 2027) | 24.74B | -- | 24.13B | 25.29B | 8 |
| FQ1 2027 (Mar 2027) | 15.27B | -- | 14.83B | 15.63B | 12 |
| FQ4 2026 (Oct 2026) | 14.33B | -- | 13.69B | 15B | 12 |
| FQ3 2026 (Jul 2026) | 14.04B | 4.05 | 13.41B | 14.69B | 22 |
| FQ2 2026 (Jun 2026) | 14.05B | 9.93 | 12.68B | 14.94B | 22 |
| FQ1 2026 (Mar 2026) | 13.31B | 13.34 | 12.02B | 14.15B | 12 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.50396 | 3.18 | 2.67604 | 84.15% |
| FQ2 2025 (Jun 2025) | 0.65 | 0.65 | 100% | |
| FQ1 2025 (Mar 2025) | 0.85 | 0.85 | 100% | |
| FQ1 2017 (Mar 2017) | -0.55 | -0.55 | 100% | |
| FQ2 2017 (Jun 2017) | -0.62 | -0.62 | 100% | |
| FQ3 2017 (Sep 2017) | -0.84 | -0.84 | 100% | |
| FQ4 2017 (Dec 2017) | -0.38 | -0.38 | 100% | |
| FQ4 2024 (Dec 2024) | 3.27 | 3.27 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $12.51B | $13.47B | $960.21M | 7.13% |
| FQ2 2025 (Jun 2025) | $0B | $12.65B | $12651M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $11.53B | $11533M | 100% |
| FQ1 2017 (Mar 2017) | $0B | $1.53B | $1529M | 100% |
| FQ2 2017 (Jun 2017) | $0B | $1.81B | $1813M | 100% |
| FQ3 2017 (Sep 2017) | $0B | $2.15B | $2149M | 100% |
| FQ4 2017 (Dec 2017) | $0B | $2.44B | $2441M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $11.96B | $11959M | 100% |